Home � Products & Services � Benchmarking Reports � Medical Affairs � Medical Affairs Excellence

Assessing the Impact of Medical Affairs: Embrace New Measurement Strategies to Promote Your Value Story, Increase Impact, and Gain Resources

Download FREE Excerpt

ID: POP-394

Features:

15 Info Graphics

16 Data Graphics

180+ Metrics

37 Narratives

Pages: 39

Published: 2024

Delivery Format: Shipped

License Options:
$4500 - 1 user
$13500 - Up to 5 users
$22500 - Up to 20 users

Buy Now

919-403-0251

Schedule a Meeting

STUDY OVERVIEW
BENCHMARK CLASS
STUDY SNAPSHOT
KEY FINDINGS
VIEW TOC AND LIST OF EXHIBITS

As the demands on Medical Affairs teams continue to grow, demonstrating value and ensuring adequate investment requires focusing on measurable outcomes which align with overall business success. By moving beyond execution-based metrics to embrace outcomes-based measures, Medical Affairs leaders can better connect their contributions to real-world results, thereby strengthening their value story through clear impact propositions.

Best Practices LLC undertook this benchmarking research to identify innovative strategies that Medical Affairs groups are adopting to redefine "impact" and link their activities to tangible outcomes, care gaps, and stakeholder engagement success. With detailed findings and industry benchmarks, this report is your guide to driving higher medical impact, overcoming measurement hurdles, elevating your value story, and making a compelling case for increased resources.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Biotech; Manufacturing; Health Care; Medical Device; Consumer Products; Clinical Research; Laboratories

Companies Profiled:
AbbVie; Alkermes; Astellas; AstraZeneca; Axsome Therapeutics; Biogen; BioMarin; Boehringer Ingelheim; Daiichi Sankyo; Eisai; Gilead Sciences; Jazz Pharmaceuticals; Johnson & Johnson; Novartis; Novo Nordisk; PDS Biotechnology; Pfizer; Regeneron; Sanofi; scPharmaceuticals; Takeda Pharmaceuticals; Vertex Pharmaceuticals; Viatris

Study Snapshot

Best Practices, LLC engaged 34 Medical Affairs leaders from 23 leading biopharma companies in this research through a benchmarking survey. Deep-dive interviews were also conducted with participating Medical Affairs leaders to capture additional insights and nuances of impact.

Key topics covered in this report include:

Driving Medical Impact
Measuring and Improving Impact
Linking Medical Strategy to Business Success
Impact Measurement Hurdles
Commercial Co-funding
Making the Case for Medical Affairs Value
Key Success Factors for High Medical Impact

Key Findings

Select key insights uncovered from this report are noted below. Detailed findings are available in the full report.

Measuring Impact with Key Indicators: Improved outcomes (52%), reach (44%), influenced guidelines (29%), and activated clinicians / advocates (25%) are among the critical metrics which best indicate Medical impact within benchmark organizations.

Impact Measurement Hurdles: Resource limitations (such as access to funding and data) are the biggest impediments to impact measurement.

Table of Contents

Sr. No.	Topic	Slide No.
I.	Executive Summary	Pg. 5-10
II.	Medical Impact and Supporting the Entire World of Care	Pg. 11-15
III.	Measuring What Matters	Pg. 16-29
IV.	Making the Business Case for Medical Affairs	Pg. 30-35
V.	Participant Demographics	Pg. 36-38
VI.	About Best Practices, LLC	Pg. 39

List of Charts & Exhibits

I. Executive Summary

Tracking Medical Affairs’ growth in impact measurement capabilities
Data summary of key study findings
Addressing care gaps in the patient treatment pathway
Linking Medical strategy to business success

II. Medical Impact and Supporting the Entire World of Care

Current level of Medical impact
Medical Affairs’ success in generating measurable impact on external stakeholder objectives
Defining Medical impact: Participant narratives
Supporting the entire world of care

III. Measuring What Matters

Importance of Diagnosis & Testing and Treatment & Adherence metrics for demonstrating Medical impact
Top actions to drive increased diagnosis outcomes
Tactics for improving number of patients treated
Measuring Medical impact with key indicators
Top actions to drive increased impact
Linking Medical impact to HCP behavior
Linking Medical impact to patient outcomes
Linking Medical impact to ROI
Identifying and addressing market and care gaps
Linking Medical strategy to business success
Key insights that drive Medical impact
Examples of recently-adopted measures to drive Medical impact

IV. Making the Business Case for Medical Affairs

Significant hurdles in measuring external impact and communicating Medical Affairs value
Commercial co-sponsorship of Medical Affairs initiatives
Effective story and data elements for making a business case for increased Medical resources
Lessons for effectively communicating Medical Affairs value to senior leadership
Top supporting capabilities for high medical impact

V. Participant Demographics

Therapeutic area(s) of focus for benchmark partners
Region or country currently supported by benchmark Medical Affairs partners